Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.
de Boer
R A
RA
University Hospital Groningen, Thoraxcenter, Department of Cardiology, P.O. Box 30001, 9700 RB, Groningen, Netherlands.
Siebelink
H J
HJ
Tio
R A
RA
Boomsma
F
F
van Veldhuisen
D J
DJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D002908:Chronic Disease; D004311:Double-Blind Method; D016228:Endothelial Growth Factors / Q000097:blood*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008222:Lymphokines / Q000097:blood* / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D016228:Endothelial Growth Factors; D008222:Lymphokines; D011412:Propanolamines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000077261:Carvedilol; D009320:Atrial Natriuretic Factor